STADA Arzneimittel Aktiengesellschaft (ETR:SAZ) Trading Up ∞ – Still a Buy?

STADA Arzneimittel Aktiengesellschaft (ETR:SAZGet Free Report) was up ∞ during trading on Tuesday . The company traded as high as €80.98 ($88.99) and last traded at €80.40 ($88.35). Approximately 92,068 shares traded hands during trading, an increase of 78% from the average daily volume of 51,761 shares.

STADA Arzneimittel Aktiengesellschaft Stock Up ∞

The firm’s 50 day moving average price is €80.40 and its two-hundred day moving average price is €80.40.

About STADA Arzneimittel Aktiengesellschaft

(Get Free Report)

STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidin Naloxone for pain; Atorvastatin for elevated cholesterol levels; Epoetin zeta for anemia; Diclofenac for pain/inflammation; and Pantoprazole for gastric ulcer/reflux.

Featured Stories

Receive News & Ratings for STADA Arzneimittel Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STADA Arzneimittel Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.